Combined plasma levels of A-type-natriuretic peptide and adrenomedullin are associated with appropriate anti-arrhythmia therapy in patients with an implantable cardioverter defibrillator but no prior device therapy.
Saved in:
| Title: | Combined plasma levels of A-type-natriuretic peptide and adrenomedullin are associated with appropriate anti-arrhythmia therapy in patients with an implantable cardioverter defibrillator but no prior device therapy. |
|---|---|
| Authors: | Beygui F; Cardiology Department, Caen University Hospital, Caen, France.; INSERM UMRS 1237, Université de Caen-Normandie, Caen, France.; ACTION Study Group, Pitié-Salpêtrière University Hospital, Paris, France., Roule V; Cardiology Department, Caen University Hospital, Caen, France.; INSERM UMRS 1237, Université de Caen-Normandie, Caen, France.; ACTION Study Group, Pitié-Salpêtrière University Hospital, Paris, France., Gandjbakhch E; ACTION Study Group, Pitié-Salpêtrière University Hospital, Paris, France.; Cardiology Department, Pitié-Salpêtrière University Hospital, Paris, France.; INSERM UMRS 1166, Sorbonne Université, Paris, France., Ollitrault P; Cardiology Department, Caen University Hospital, Caen, France., Silvain J; ACTION Study Group, Pitié-Salpêtrière University Hospital, Paris, France.; Cardiology Department, Pitié-Salpêtrière University Hospital, Paris, France.; INSERM UMRS 1166, Sorbonne Université, Paris, France., Milliez P; Cardiology Department, Caen University Hospital, Caen, France.; INSERM UMRS 1237, Université de Caen-Normandie, Caen, France., Vignolles N; ACTION Study Group, Pitié-Salpêtrière University Hospital, Paris, France.; Cardiology Department, Pitié-Salpêtrière University Hospital, Paris, France.; INSERM UMRS 1166, Sorbonne Université, Paris, France., Zeitouni M; ACTION Study Group, Pitié-Salpêtrière University Hospital, Paris, France.; Cardiology Department, Pitié-Salpêtrière University Hospital, Paris, France.; INSERM UMRS 1166, Sorbonne Université, Paris, France., Guedeney P; ACTION Study Group, Pitié-Salpêtrière University Hospital, Paris, France.; Cardiology Department, Pitié-Salpêtrière University Hospital, Paris, France.; INSERM UMRS 1166, Sorbonne Université, Paris, France., Champ-Rigot L; Cardiology Department, Caen University Hospital, Caen, France.; INSERM UMRS 1237, Université de Caen-Normandie, Caen, France., Blanchart K; Cardiology Department, Caen University Hospital, Caen, France.; INSERM UMRS 1237, Université de Caen-Normandie, Caen, France., Montalescot G; ACTION Study Group, Pitié-Salpêtrière University Hospital, Paris, France.; Cardiology Department, Pitié-Salpêtrière University Hospital, Paris, France.; INSERM UMRS 1166, Sorbonne Université, Paris, France. |
| Source: | Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals [Biomarkers] 2025 Jul; Vol. 30 (5), pp. 371-379. Date of Electronic Publication: 2025 Sep 08. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Tayor & Francis Country of Publication: England NLM ID: 9606000 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1366-5804 (Electronic) Linking ISSN: 1354750X NLM ISO Abbreviation: Biomarkers Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
